Rho kinase promotes alloimmune responses by regulating the proliferation and structure of T cells

J Immunol. 2003 Jul 1;171(1):96-105. doi: 10.4049/jimmunol.171.1.96.

Abstract

Coordinated rearrangements of the actin-myosin cytoskeleton facilitate early and late events in T cell activation and signal transduction. As many important features of cell shape rearrangement involve small GTP-binding proteins, we examined the contribution of Rho kinase to the functions of mature T cells. Inhibitors of the Rho kinase pathway all had similar actions to inhibit the proliferation of primary lymphocyte cultures. Likewise, transfection of the human Jurkat T cell line with a dominant negative, kinase-defective mutant of Rho kinase diminished Jurkat cell proliferation. Furthermore, inhibition of Rho kinase substantially attenuated the program of cytokine gene expression that characterizes T cell activation, blocked actomyosin polymerization, and prevented aggregation of the TCR/CD3 complex colocalized with lipid rafts. These actions are relevant to immune responses in vivo, as treatment with a Rho kinase inhibitor considerably prolonged the survival of fully allogeneic heart transplants in mice and diminished intragraft expression of cytokine mRNAs. Thus, Rho GTPases acting through Rho kinase play a unique role in T cell activation during cellular immune responses by promoting structural rearrangements that are critical for T cell signaling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Amides / pharmacology
  • Animals
  • CD3 Complex / immunology
  • Cell Division / drug effects
  • Cell Division / immunology
  • Concanavalin A / pharmacology
  • Cytoskeleton / immunology*
  • Enzyme Activation / immunology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Graft Rejection / enzymology
  • Graft Rejection / immunology
  • Growth Inhibitors / pharmacology
  • Heart Transplantation / immunology
  • Humans
  • Immune Sera / pharmacology
  • Intracellular Signaling Peptides and Proteins
  • Isoantigens / immunology*
  • Jurkat Cells
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology
  • Male
  • Membrane Microdomains / enzymology
  • Membrane Microdomains / immunology
  • Membrane Microdomains / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Mutation
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / physiology*
  • Pyridines / pharmacology
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • Transfection
  • rho-Associated Kinases

Substances

  • Actins
  • Amides
  • CD3 Complex
  • Enzyme Inhibitors
  • Growth Inhibitors
  • Immune Sera
  • Intracellular Signaling Peptides and Proteins
  • Isoantigens
  • Pyridines
  • Concanavalin A
  • Y 27632
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases